Literature DB >> 12431290

Deep venous thrombosis and thromboembolism in patients with cervical spinal cord injuries.

M N Hadley, B C Walters, P A Grabb, N M Oyesiku, G J Przybylski, D K Resnick, T C Ryken.   

Abstract

STANDARDS: Prophylactic treatment of thromboembolism in patients with severe motor deficits due to spinal cord injury is recommended. The use of low-molecular-weight heparins, rotating beds, adjusted dose heparin, or a combination of modalities is recommended as a prophylactic treatment strategy. Low-dose heparin in combination with pneumatic compression stockings or electrical stimulation is recommended as a prophylactic treatment strategy. GUIDELINES: Low-dose heparin therapy alone is not recommended as a prophylactic treatment strategy. Oral anticoagulation alone is not recommended as a prophylactic treatment strategy. OPTIONS: Duplex Doppler ultrasound, impedance plethysmography, and venography are recommended for use as diagnostic tests for deep venous thrombosis in the spinal cord-injured patient population. A 3-month duration of prophylactic treatment for deep venous thrombosis and pulmonary embolism is recommended. Vena cava filters are recommended for patients who do not respond to anticoagulation or who are not candidates for anticoagulation therapy and/or mechanical devices.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12431290     DOI: 10.1097/00006123-200203001-00014

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  2 in total

1.  Dalteparin vs low-dose unfractionated heparin for prophylaxis against clinically evident venous thromboembolism in acute traumatic spinal cord injury: a retrospective cohort study.

Authors:  Scott Worley; Christine Short; Jeff Pike; David Anderson; Jo-Anne Douglas; Kara Thompson
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

2.  A Clinical Practice Guideline for the Management of Acute Spinal Cord Injury: Introduction, Rationale, and Scope.

Authors:  Michael G Fehlings; Lindsay A Tetreault; Jefferson R Wilson; Brian K Kwon; Anthony S Burns; Allan R Martin; Gregory Hawryluk; James S Harrop
Journal:  Global Spine J       Date:  2017-09-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.